Dosecann has announced the launch of Dosecann Capsules, a cannabis product that combines cannabinoids with Ahiflower oil, a source of omega oils.
The capsules were developed by a team of scientists and researchers at the company’s laboratory at in Charlottetown, PEI, under the direction of Dr Bob Chapman, Dosecann’s CSO.
“Our innovation team has thoroughly researched and rigorously tested Dosecann Capsules to ensure they are consistent with our guiding principles of quality, safety and efficacy,” said Chapman. “Balanced, omega-rich Ahiflower oil has proven to be an ideal carrier oil for Dosecann’s refined cannabis resins, which feature the full range of cannabinoids, terpenes, flavonoids and other phytonutrients found in the cannabis plant. The resulting capsule formulations offer all the natural qualities of the cannabis and Ahiflower plants in a convenient capsule format that wellness consumers are sure to love.”
The cannabinoids in the capsules are derived from a whole-plant cannabis resin that reportedly preserves the character of the cannabis plant. Through a process of cold-ethanol extraction, this broad-spectrum cannabis resin is refined and combined with omega-rich Ahiflower oil.
Ahiflower is a source of sustainable, traceable, and balanced omega 3-6-9 oil, with a more biologically advanced omega fatty acid composition than any other natural plant-based oil. It also provides a 4:1 ratio of the essential omega 3-6 fatty acids the body needs. It’s been shown in clinical trials to be safe, well-tolerated, and to increase the concentrations of long-chain omega-3 fatty acids up to four times more effectively than flaxseed oil.
According to Healthline, essential polyunsaturated omega 3-6-9 oils are clinically associated with a range of health benefits, such as improving cardiovascular health, supporting mental health, fighting inflammation and benefitting skin and hair.
Each capsule contains 25 mg of CBD, 1 mg of THC and 500 mg of Ahiflower oil, sealed in Lonza’s Licaps Capsugel capsules.